Gene Symbol | Gene ID | Gene Info |
---|---|---|
Alx4
|
ENSMUSG00000040310.6 | aristaless-like homeobox 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_93597035_93597186 | Alx4 | 45274 | 0.154786 | 0.44 | 4.1e-04 | Click! |
chr2_93613311_93613462 | Alx4 | 28998 | 0.200044 | -0.40 | 1.6e-03 | Click! |
chr2_93619471_93619639 | Alx4 | 22829 | 0.216400 | 0.39 | 1.9e-03 | Click! |
chr2_93618508_93618830 | Alx4 | 23715 | 0.214140 | 0.34 | 8.7e-03 | Click! |
chr2_93640612_93640763 | Alx4 | 1697 | 0.447593 | 0.29 | 2.3e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_83715222_83716973 | 11.44 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
5284 |
0.15 |
chr12_52700044_52701597 | 11.28 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
1437 |
0.46 |
chr11_34315414_34316667 | 10.77 |
Insyn2b |
inhibitory synaptic factor family member 2B |
1218 |
0.45 |
chr13_83739310_83740387 | 10.73 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
985 |
0.29 |
chr12_71048832_71049275 | 10.72 |
Arid4a |
AT rich interactive domain 4A (RBP1-like) |
712 |
0.65 |
chr10_29143400_29144848 | 10.67 |
Soga3 |
SOGA family member 3 |
65 |
0.5 |
chr2_6881042_6881689 | 10.58 |
Gm13389 |
predicted gene 13389 |
2905 |
0.24 |
chr3_154816919_154817899 | 10.14 |
Gm18589 |
predicted gene, 18589 |
22198 |
0.2 |
chr15_25415436_25415919 | 9.78 |
Gm48957 |
predicted gene, 48957 |
614 |
0.58 |
chr11_36676450_36677161 | 9.64 |
Tenm2 |
teneurin transmembrane protein 2 |
940 |
0.7 |
chr1_138346039_138346510 | 9.49 |
Gm28500 |
predicted gene 28500 |
30990 |
0.17 |
chr1_66386919_66387899 | 9.46 |
Map2 |
microtubule-associated protein 2 |
398 |
0.87 |
chrX_153501207_153502250 | 9.30 |
Ubqln2 |
ubiquilin 2 |
3501 |
0.22 |
chr8_41054476_41055299 | 9.25 |
Mtus1 |
mitochondrial tumor suppressor 1 |
93 |
0.95 |
chr13_83735228_83735549 | 9.16 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2822 |
0.16 |
chr10_90577565_90578158 | 9.13 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
869 |
0.72 |
chr9_41585694_41587243 | 8.93 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1301 |
0.29 |
chr18_37217058_37218378 | 8.80 |
Gm10544 |
predicted gene 10544 |
39196 |
0.08 |
chr8_34890130_34891317 | 8.53 |
Tnks |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase |
572 |
0.8 |
chr14_100374663_100375528 | 8.52 |
Gm26367 |
predicted gene, 26367 |
43388 |
0.15 |
chr1_81077232_81078427 | 8.32 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
246 |
0.96 |
chr2_18042311_18043883 | 8.02 |
Skida1 |
SKI/DACH domain containing 1 |
1475 |
0.25 |
chr16_43504464_43505047 | 7.97 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
1058 |
0.61 |
chr10_90578974_90579573 | 7.93 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
2281 |
0.42 |
chr4_24429141_24429555 | 7.74 |
Gm27243 |
predicted gene 27243 |
1542 |
0.44 |
chr13_44842150_44842855 | 7.69 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
1719 |
0.39 |
chr9_91360032_91360505 | 7.66 |
Zic4 |
zinc finger protein of the cerebellum 4 |
2145 |
0.17 |
chr3_134236641_134237783 | 7.65 |
Cxxc4 |
CXXC finger 4 |
392 |
0.78 |
chr2_57613916_57615034 | 7.60 |
Gm13532 |
predicted gene 13532 |
14753 |
0.2 |
chr2_181766837_181767244 | 7.59 |
Myt1 |
myelin transcription factor 1 |
2 |
0.97 |
chr16_77236514_77236677 | 7.55 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
276 |
0.93 |
chr2_116053626_116054503 | 7.46 |
Meis2 |
Meis homeobox 2 |
4384 |
0.2 |
chr8_93812106_93812875 | 7.44 |
Gnao1 |
guanine nucleotide binding protein, alpha O |
1177 |
0.35 |
chr8_45508499_45509041 | 7.42 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
852 |
0.61 |
chr2_152080491_152081480 | 7.35 |
Scrt2 |
scratch family zinc finger 2 |
544 |
0.7 |
chr1_42703141_42704653 | 7.21 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
4155 |
0.16 |
chr7_126951595_126952206 | 7.12 |
Sez6l2 |
seizure related 6 homolog like 2 |
934 |
0.25 |
chr12_89815214_89815490 | 7.10 |
Nrxn3 |
neurexin III |
2869 |
0.41 |
chr9_69592532_69592902 | 7.08 |
Gm47203 |
predicted gene, 47203 |
7037 |
0.25 |
chr2_65620767_65621991 | 7.03 |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
568 |
0.82 |
chr9_74977325_74977617 | 6.96 |
Fam214a |
family with sequence similarity 214, member A |
1360 |
0.45 |
chr14_98164357_98165375 | 6.96 |
Dach1 |
dachshund family transcription factor 1 |
4677 |
0.28 |
chr1_42259362_42260538 | 6.91 |
Gm28175 |
predicted gene 28175 |
1905 |
0.34 |
chr11_43270080_43270726 | 6.90 |
Gm12146 |
predicted gene 12146 |
10619 |
0.19 |
chr5_135725023_135726457 | 6.88 |
Por |
P450 (cytochrome) oxidoreductase |
12 |
0.96 |
chr4_54950838_54951442 | 6.85 |
Zfp462 |
zinc finger protein 462 |
3164 |
0.35 |
chr5_107497766_107498034 | 6.81 |
Btbd8 |
BTB (POZ) domain containing 8 |
121 |
0.94 |
chr18_23036665_23037864 | 6.70 |
Nol4 |
nucleolar protein 4 |
1392 |
0.59 |
chr10_92404661_92405130 | 6.69 |
4930401A07Rik |
RIKEN cDNA 4930401A07 gene |
3881 |
0.24 |
chr11_69834618_69835201 | 6.68 |
Nlgn2 |
neuroligin 2 |
60 |
0.9 |
chr1_186278091_186278855 | 6.64 |
Gm37491 |
predicted gene, 37491 |
68842 |
0.11 |
chr10_111247804_111248910 | 6.61 |
Osbpl8 |
oxysterol binding protein-like 8 |
289 |
0.91 |
chr14_39471112_39471496 | 6.60 |
Nrg3 |
neuregulin 3 |
1362 |
0.61 |
chr6_55678280_55679200 | 6.60 |
Neurod6 |
neurogenic differentiation 6 |
2523 |
0.32 |
chr9_35424475_35426234 | 6.59 |
Cdon |
cell adhesion molecule-related/down-regulated by oncogenes |
1766 |
0.31 |
chr13_8205494_8206737 | 6.59 |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
3193 |
0.23 |
chrX_166346941_166347276 | 6.58 |
Gpm6b |
glycoprotein m6b |
2266 |
0.36 |
chr2_140668225_140669392 | 6.54 |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
2592 |
0.43 |
chr18_57468245_57468987 | 6.52 |
Ctxn3 |
cortexin 3 |
94 |
0.97 |
chr12_49387532_49388566 | 6.50 |
3110039M20Rik |
RIKEN cDNA 3110039M20 gene |
1603 |
0.26 |
chr11_118907285_118907593 | 6.48 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
566 |
0.76 |
chr3_34653590_34654523 | 6.46 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1980 |
0.2 |
chrX_58034447_58034953 | 6.38 |
Zic3 |
zinc finger protein of the cerebellum 3 |
3690 |
0.31 |
chr7_29071185_29072068 | 6.29 |
Gm26604 |
predicted gene, 26604 |
11 |
0.87 |
chr11_94044930_94045437 | 6.29 |
Spag9 |
sperm associated antigen 9 |
818 |
0.6 |
chr7_87586513_87587584 | 6.22 |
Grm5 |
glutamate receptor, metabotropic 5 |
2650 |
0.4 |
chr17_17402413_17403374 | 6.17 |
Lix1 |
limb and CNS expressed 1 |
221 |
0.91 |
chr5_120409346_120410480 | 6.15 |
Lhx5 |
LIM homeobox protein 5 |
21786 |
0.12 |
chr2_105675959_105678109 | 6.13 |
Pax6 |
paired box 6 |
905 |
0.54 |
chr8_47284401_47285223 | 6.10 |
Stox2 |
storkhead box 2 |
4550 |
0.27 |
chr4_24429901_24430719 | 6.05 |
Gm27243 |
predicted gene 27243 |
580 |
0.79 |
chr9_41377643_41378358 | 6.04 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1439 |
0.4 |
chrX_23283125_23283785 | 6.00 |
Klhl13 |
kelch-like 13 |
1374 |
0.57 |
chr8_14382368_14383445 | 6.00 |
Dlgap2 |
DLG associated protein 2 |
910 |
0.66 |
chrX_75577044_75577513 | 6.00 |
Rab39b |
RAB39B, member RAS oncogene family |
953 |
0.4 |
chr7_62420525_62420893 | 5.95 |
Mkrn3 |
makorin, ring finger protein, 3 |
570 |
0.69 |
chr6_16727216_16727889 | 5.94 |
Gm36669 |
predicted gene, 36669 |
49972 |
0.17 |
chr9_41582824_41584205 | 5.93 |
Mir125b-1 |
microRNA 125b-1 |
1588 |
0.2 |
chr3_67892003_67892637 | 5.89 |
Iqschfp |
Iqcj and Schip1 fusion protein |
88 |
0.51 |
chr9_41587250_41587725 | 5.87 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
282 |
0.84 |
chr7_44441770_44441925 | 5.86 |
Lrrc4b |
leucine rich repeat containing 4B |
638 |
0.46 |
chr10_116096404_116096629 | 5.84 |
Taf7l2 |
Taf7l2 |
17076 |
0.23 |
chr8_109250884_109251908 | 5.84 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
1530 |
0.52 |
chr1_6733530_6734383 | 5.81 |
St18 |
suppression of tumorigenicity 18 |
914 |
0.7 |
chr19_47018258_47018719 | 5.79 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
3335 |
0.15 |
chr17_11664263_11665109 | 5.79 |
Gm10513 |
predicted gene 10513 |
67659 |
0.13 |
chrX_61116034_61117613 | 5.78 |
Cdr1os |
cerebellar degeneration related antigen 1, opposite strand |
425 |
0.47 |
chr4_110285249_110285423 | 5.75 |
Elavl4 |
ELAV like RNA binding protein 4 |
1280 |
0.61 |
chr3_8512495_8512918 | 5.75 |
Stmn2 |
stathmin-like 2 |
3120 |
0.28 |
chr12_47164059_47165060 | 5.70 |
Gm36971 |
predicted gene, 36971 |
483 |
0.87 |
chr7_36679043_36680470 | 5.69 |
Gm38285 |
predicted gene, 38285 |
15682 |
0.14 |
chrX_6169933_6171264 | 5.67 |
Nudt10 |
nudix (nucleoside diphosphate linked moiety X)-type motif 10 |
2417 |
0.31 |
chr5_116312100_116312726 | 5.67 |
B230112J18Rik |
RIKEN cDNA B230112J18 gene |
53 |
0.96 |
chr14_55056074_55056891 | 5.65 |
Gm20687 |
predicted gene 20687 |
989 |
0.3 |
chr13_94645221_94645665 | 5.62 |
Gm48287 |
predicted gene, 48287 |
1901 |
0.32 |
chr10_90830503_90831025 | 5.62 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
921 |
0.56 |
chr16_77418973_77419718 | 5.61 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
2475 |
0.17 |
chr3_88208985_88210116 | 5.57 |
Gm3764 |
predicted gene 3764 |
78 |
0.92 |
chr12_61525659_61526870 | 5.56 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
2316 |
0.3 |
chr3_84955400_84955669 | 5.51 |
Fbxw7 |
F-box and WD-40 domain protein 7 |
3388 |
0.35 |
chr4_35844509_35845617 | 5.50 |
Lingo2 |
leucine rich repeat and Ig domain containing 2 |
141 |
0.98 |
chr18_54719777_54720132 | 5.49 |
Gm5821 |
predicted gene 5821 |
46178 |
0.16 |
chr16_28927533_28927764 | 5.44 |
Mb21d2 |
Mab-21 domain containing 2 |
2025 |
0.41 |
chr1_172056022_172057415 | 5.40 |
Nhlh1 |
nescient helix loop helix 1 |
855 |
0.45 |
chr18_80984086_80984990 | 5.39 |
Sall3 |
spalt like transcription factor 3 |
1998 |
0.23 |
chr18_80979961_80981696 | 5.36 |
Sall3 |
spalt like transcription factor 3 |
5708 |
0.14 |
chr5_131615202_131615755 | 5.36 |
2810432F15Rik |
RIKEN cDNA 2810432F15 gene |
40 |
0.94 |
chr8_96455054_96456367 | 5.30 |
Gm32122 |
predicted gene, 32122 |
51848 |
0.14 |
chrX_166347339_166348040 | 5.29 |
Gpm6b |
glycoprotein m6b |
2847 |
0.32 |
chr13_28881136_28881895 | 5.22 |
2610307P16Rik |
RIKEN cDNA 2610307P16 gene |
1941 |
0.32 |
chr9_41584760_41585051 | 5.22 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
2864 |
0.14 |
chr4_125492765_125493053 | 5.18 |
Grik3 |
glutamate receptor, ionotropic, kainate 3 |
2209 |
0.31 |
chr4_48586297_48586448 | 5.18 |
Tmeff1 |
transmembrane protein with EGF-like and two follistatin-like domains 1 |
821 |
0.65 |
chrX_166344665_166345995 | 5.16 |
Gpm6b |
glycoprotein m6b |
488 |
0.85 |
chr5_48598987_48600332 | 5.13 |
Kcnip4 |
Kv channel interacting protein 4 |
23 |
0.97 |
chr10_109832096_109833441 | 5.12 |
Nav3 |
neuron navigator 3 |
453 |
0.9 |
chr2_73775928_73776225 | 5.11 |
Chn1 |
chimerin 1 |
730 |
0.7 |
chr5_90339159_90340201 | 5.10 |
Ankrd17 |
ankyrin repeat domain 17 |
63 |
0.98 |
chr9_4794349_4794500 | 5.09 |
Gria4 |
glutamate receptor, ionotropic, AMPA4 (alpha 4) |
1095 |
0.68 |
chr10_21882056_21883261 | 5.08 |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
289 |
0.9 |
chr10_57784547_57786586 | 5.08 |
Fabp7 |
fatty acid binding protein 7, brain |
643 |
0.68 |
chr3_4796861_4798079 | 5.08 |
1110015O18Rik |
RIKEN cDNA 1110015O18 gene |
88 |
0.98 |
chr15_92598307_92599654 | 5.06 |
Pdzrn4 |
PDZ domain containing RING finger 4 |
1854 |
0.49 |
chr18_72349127_72350542 | 5.05 |
Dcc |
deleted in colorectal carcinoma |
1183 |
0.64 |
chr18_81165961_81166641 | 5.02 |
4930594M17Rik |
RIKEN cDNA 4930594M17 gene |
69765 |
0.09 |
chr12_41483283_41485192 | 5.00 |
Lrrn3 |
leucine rich repeat protein 3, neuronal |
2194 |
0.36 |
chr15_18820164_18820708 | 4.97 |
Cdh10 |
cadherin 10 |
107 |
0.96 |
chr6_8955848_8957226 | 4.97 |
Nxph1 |
neurexophilin 1 |
6861 |
0.32 |
chr11_94046539_94046899 | 4.90 |
Spag9 |
sperm associated antigen 9 |
2354 |
0.27 |
chr11_104233637_104234521 | 4.89 |
Mapt |
microtubule-associated protein tau |
2495 |
0.22 |
chr4_70530858_70531844 | 4.89 |
Megf9 |
multiple EGF-like-domains 9 |
3577 |
0.38 |
chr14_121738221_121738727 | 4.87 |
Dock9 |
dedicator of cytokinesis 9 |
387 |
0.9 |
chr13_34132999_34133150 | 4.86 |
Gm36500 |
predicted gene, 36500 |
786 |
0.46 |
chr1_143644977_143645827 | 4.85 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
2877 |
0.24 |
chr3_34654574_34655689 | 4.85 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
905 |
0.42 |
chr3_17787332_17788058 | 4.83 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
2226 |
0.29 |
chr16_67618113_67618498 | 4.81 |
Cadm2 |
cell adhesion molecule 2 |
2188 |
0.39 |
chr1_66324716_66324867 | 4.78 |
Map2 |
microtubule-associated protein 2 |
2689 |
0.25 |
chr4_33926104_33927188 | 4.76 |
Cnr1 |
cannabinoid receptor 1 (brain) |
444 |
0.88 |
chr1_77505286_77506951 | 4.75 |
Epha4 |
Eph receptor A4 |
8961 |
0.18 |
chr8_49462071_49462635 | 4.74 |
4930555F03Rik |
RIKEN cDNA 4930555F03 gene |
970 |
0.52 |
chr12_98577628_98578516 | 4.73 |
Kcnk10 |
potassium channel, subfamily K, member 10 |
238 |
0.9 |
chr2_14740186_14740953 | 4.72 |
Gm10848 |
predicted gene 10848 |
847 |
0.36 |
chr5_150261018_150262108 | 4.72 |
Fry |
FRY microtubule binding protein |
1796 |
0.34 |
chr10_73821409_73822534 | 4.71 |
Pcdh15 |
protocadherin 15 |
28 |
0.99 |
chr13_83736071_83736534 | 4.70 |
Gm33366 |
predicted gene, 33366 |
2233 |
0.18 |
chr18_59062200_59063436 | 4.70 |
Minar2 |
membrane integral NOTCH2 associated receptor 2 |
307 |
0.94 |
chr1_42686011_42687379 | 4.69 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
6398 |
0.14 |
chr1_84934038_84935232 | 4.67 |
Slc16a14 |
solute carrier family 16 (monocarboxylic acid transporters), member 14 |
222 |
0.91 |
chr11_118907979_118908224 | 4.66 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
96 |
0.97 |
chr13_81630063_81630959 | 4.65 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
2628 |
0.28 |
chr18_79106634_79106785 | 4.63 |
Setbp1 |
SET binding protein 1 |
2682 |
0.4 |
chr8_54956010_54956394 | 4.63 |
Gpm6a |
glycoprotein m6a |
1359 |
0.38 |
chrX_160992631_160993204 | 4.62 |
Cdkl5 |
cyclin-dependent kinase-like 5 |
1787 |
0.46 |
chrX_147552057_147552289 | 4.62 |
Lrch2 |
leucine-rich repeats and calponin homology (CH) domain containing 2 |
1877 |
0.42 |
chr9_59033803_59034249 | 4.61 |
Neo1 |
neogenin |
2399 |
0.36 |
chr4_90437640_90438299 | 4.61 |
Gm12635 |
predicted gene 12635 |
14905 |
0.24 |
chrX_133682515_133683917 | 4.60 |
Pcdh19 |
protocadherin 19 |
1775 |
0.49 |
chr18_80982763_80983698 | 4.59 |
Sall3 |
spalt like transcription factor 3 |
3306 |
0.17 |
chr16_42339015_42340584 | 4.59 |
Gap43 |
growth associated protein 43 |
852 |
0.7 |
chr1_20428374_20428954 | 4.57 |
Gm15795 |
predicted gene 15795 |
16146 |
0.17 |
chr6_97938208_97938822 | 4.56 |
Mitf |
melanogenesis associated transcription factor |
2403 |
0.38 |
chr6_143259703_143261097 | 4.54 |
D6Ertd474e |
DNA segment, Chr 6, ERATO Doi 474, expressed |
14507 |
0.2 |
chr1_72534545_72535249 | 4.54 |
Marchf4 |
membrane associated ring-CH-type finger 4 |
2033 |
0.35 |
chr2_165367693_165368982 | 4.54 |
Zfp663 |
zinc finger protein 663 |
386 |
0.8 |
chr5_112574293_112574972 | 4.53 |
Sez6l |
seizure related 6 homolog like |
2236 |
0.24 |
chr16_91320391_91321321 | 4.51 |
Gm15966 |
predicted gene 15966 |
4884 |
0.15 |
chr1_66323360_66324079 | 4.49 |
Map2 |
microtubule-associated protein 2 |
1617 |
0.37 |
chr13_83732205_83734272 | 4.49 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
672 |
0.58 |
chr7_137318563_137320070 | 4.48 |
Ebf3 |
early B cell factor 3 |
4871 |
0.21 |
chr5_116895246_116895637 | 4.48 |
Gm43122 |
predicted gene 43122 |
64887 |
0.1 |
chr6_112943851_112944495 | 4.47 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
2581 |
0.19 |
chr5_27841594_27842778 | 4.47 |
Htr5a |
5-hydroxytryptamine (serotonin) receptor 5A |
37 |
0.97 |
chr13_52976109_52977372 | 4.47 |
Nfil3 |
nuclear factor, interleukin 3, regulated |
4333 |
0.2 |
chr5_126768981_126769769 | 4.46 |
Gm33347 |
predicted gene, 33347 |
42091 |
0.14 |
chr5_98182267_98183697 | 4.44 |
Prdm8 |
PR domain containing 8 |
2004 |
0.26 |
chr3_107114280_107114523 | 4.44 |
Kcna2 |
potassium voltage-gated channel, shaker-related subfamily, member 2 |
11719 |
0.15 |
chr10_40885530_40885990 | 4.44 |
Wasf1 |
WAS protein family, member 1 |
1933 |
0.32 |
chrX_69363262_69363944 | 4.44 |
Gm14705 |
predicted gene 14705 |
2334 |
0.33 |
chr2_73275777_73276681 | 4.44 |
Sp9 |
trans-acting transcription factor 9 |
4263 |
0.18 |
chr13_78189592_78191761 | 4.43 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
233 |
0.9 |
chr1_184997307_184998530 | 4.43 |
Mark1 |
MAP/microtubule affinity regulating kinase 1 |
1557 |
0.41 |
chr7_137312340_137312685 | 4.42 |
Ebf3 |
early B cell factor 3 |
1404 |
0.43 |
chr17_4997980_4998900 | 4.42 |
Arid1b |
AT rich interactive domain 1B (SWI-like) |
2011 |
0.4 |
chr15_77150114_77150989 | 4.41 |
Rbfox2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
3005 |
0.19 |
chr13_83718912_83719403 | 4.41 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2224 |
0.22 |
chr19_14590125_14590853 | 4.41 |
Tle4 |
transducin-like enhancer of split 4 |
5050 |
0.31 |
chr14_66865047_66865736 | 4.40 |
Dpysl2 |
dihydropyrimidinase-like 2 |
3297 |
0.19 |
chr13_83729448_83730058 | 4.40 |
Gm26803 |
predicted gene, 26803 |
171 |
0.91 |
chr18_14502717_14503687 | 4.40 |
Gm50098 |
predicted gene, 50098 |
11197 |
0.23 |
chr4_49842278_49843034 | 4.39 |
Grin3a |
glutamate receptor ionotropic, NMDA3A |
2893 |
0.36 |
chr6_7554855_7556232 | 4.38 |
Tac1 |
tachykinin 1 |
447 |
0.85 |
chr9_60686843_60686994 | 4.38 |
Lrrc49 |
leucine rich repeat containing 49 |
616 |
0.74 |
chr3_89521563_89522618 | 4.35 |
Kcnn3 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 |
1926 |
0.28 |
chr18_69350551_69351104 | 4.35 |
Tcf4 |
transcription factor 4 |
1883 |
0.45 |
chr13_97248475_97250229 | 4.34 |
Enc1 |
ectodermal-neural cortex 1 |
8247 |
0.17 |
chr1_70726785_70727115 | 4.32 |
Vwc2l |
von Willebrand factor C domain-containing protein 2-like |
1027 |
0.69 |
chr4_83794538_83795088 | 4.31 |
Gm26968 |
predicted gene, 26968 |
51136 |
0.14 |
chr1_177444257_177446079 | 4.30 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
230 |
0.9 |
chr15_88561170_88561806 | 4.30 |
Zdhhc25 |
zinc finger, DHHC domain containing 25 |
38814 |
0.19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.2 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
2.9 | 11.4 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.8 | 8.5 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.7 | 8.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.5 | 17.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
2.4 | 7.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
2.2 | 8.7 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
2.2 | 6.5 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
2.1 | 6.4 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
2.1 | 22.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
2.1 | 14.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.0 | 4.0 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
2.0 | 5.9 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
2.0 | 15.7 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.9 | 7.7 | GO:0060594 | mammary gland specification(GO:0060594) |
1.7 | 5.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
1.6 | 6.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.6 | 4.9 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.6 | 6.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
1.6 | 7.8 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.5 | 6.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.5 | 6.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.5 | 10.2 | GO:0097264 | self proteolysis(GO:0097264) |
1.4 | 7.2 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.4 | 5.5 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
1.3 | 10.5 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.3 | 7.8 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
1.3 | 3.9 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.3 | 12.7 | GO:0060013 | righting reflex(GO:0060013) |
1.3 | 3.8 | GO:0021828 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
1.2 | 3.7 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.2 | 3.7 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
1.2 | 6.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.2 | 4.8 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.2 | 2.3 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.2 | 8.1 | GO:0071625 | vocalization behavior(GO:0071625) |
1.2 | 5.8 | GO:0072017 | distal tubule development(GO:0072017) |
1.2 | 3.5 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.1 | 4.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.1 | 3.4 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
1.1 | 2.2 | GO:0008050 | female courtship behavior(GO:0008050) |
1.1 | 3.3 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
1.1 | 4.4 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
1.1 | 4.3 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.1 | 3.2 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.1 | 3.2 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
1.1 | 3.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.0 | 3.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.0 | 3.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.0 | 5.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
1.0 | 2.0 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
1.0 | 1.0 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.0 | 3.0 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.0 | 3.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.0 | 1.9 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.0 | 1.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.0 | 3.9 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.0 | 1.9 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.9 | 0.9 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.9 | 1.9 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.9 | 9.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.9 | 5.6 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
0.9 | 2.8 | GO:1903365 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
0.9 | 1.9 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.9 | 2.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.9 | 2.7 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.9 | 3.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.9 | 4.5 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.9 | 0.9 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.9 | 3.5 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.9 | 3.5 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.9 | 3.5 | GO:0090427 | activation of meiosis(GO:0090427) |
0.9 | 14.0 | GO:0060074 | synapse maturation(GO:0060074) |
0.9 | 1.7 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.9 | 10.3 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.8 | 3.3 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
0.8 | 2.4 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.8 | 3.2 | GO:0007412 | axon target recognition(GO:0007412) |
0.8 | 8.0 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.8 | 3.2 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.8 | 3.9 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.8 | 1.5 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.8 | 1.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.8 | 12.8 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.8 | 1.5 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.7 | 1.5 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.7 | 9.6 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.7 | 5.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.7 | 0.7 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.7 | 2.9 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.7 | 0.7 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.7 | 10.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.7 | 2.1 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.7 | 0.7 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.7 | 2.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.7 | 3.4 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.7 | 38.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.7 | 1.3 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.7 | 7.8 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.7 | 2.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.6 | 0.6 | GO:0060166 | olfactory pit development(GO:0060166) |
0.6 | 1.9 | GO:0022038 | corpus callosum development(GO:0022038) |
0.6 | 3.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.6 | 3.0 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.6 | 5.4 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.6 | 1.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.6 | 1.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.6 | 1.8 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.6 | 1.2 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.6 | 2.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.6 | 3.3 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.6 | 19.9 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.6 | 2.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.5 | 1.1 | GO:0007619 | courtship behavior(GO:0007619) |
0.5 | 1.6 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.5 | 1.1 | GO:0060618 | nipple development(GO:0060618) |
0.5 | 2.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.5 | 1.6 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.5 | 2.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.5 | 1.0 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.5 | 3.6 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.5 | 2.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.5 | 1.5 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.5 | 3.0 | GO:0015884 | folic acid transport(GO:0015884) |
0.5 | 7.9 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.5 | 1.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.5 | 1.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.5 | 0.5 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.5 | 1.0 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.5 | 3.8 | GO:0001964 | startle response(GO:0001964) |
0.5 | 35.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.5 | 3.8 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.5 | 1.9 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.5 | 1.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.5 | 1.9 | GO:0001927 | exocyst assembly(GO:0001927) |
0.5 | 1.9 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.5 | 1.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.5 | 1.4 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.5 | 0.9 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.5 | 1.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.5 | 1.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.5 | 1.8 | GO:0060179 | male mating behavior(GO:0060179) |
0.5 | 0.5 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.4 | 0.9 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.4 | 1.7 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.4 | 0.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.4 | 0.8 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.4 | 1.7 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.4 | 0.8 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.4 | 1.2 | GO:0030432 | peristalsis(GO:0030432) |
0.4 | 0.8 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.4 | 1.6 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.4 | 1.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.4 | 0.4 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.4 | 0.8 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.4 | 0.4 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.4 | 0.8 | GO:0015817 | histidine transport(GO:0015817) |
0.4 | 1.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.4 | 2.7 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.4 | 1.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.4 | 1.6 | GO:0030091 | protein repair(GO:0030091) |
0.4 | 1.2 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.4 | 4.2 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.4 | 0.8 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.4 | 1.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 0.7 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.4 | 3.3 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.4 | 0.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.4 | 0.7 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.4 | 0.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.4 | 2.5 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
0.4 | 2.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.4 | 0.4 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.4 | 8.8 | GO:0021766 | hippocampus development(GO:0021766) |
0.3 | 1.4 | GO:0046909 | intermembrane transport(GO:0046909) |
0.3 | 1.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 0.7 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.3 | 4.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.3 | 4.1 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.3 | 1.3 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 6.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.3 | 1.3 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.3 | 1.3 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.3 | 0.7 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.3 | 2.0 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.3 | 4.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.3 | 1.9 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.3 | 1.0 | GO:0044849 | estrous cycle(GO:0044849) |
0.3 | 1.6 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.3 | 0.6 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.3 | 0.6 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.3 | 0.6 | GO:0060437 | lung growth(GO:0060437) |
0.3 | 0.6 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.3 | 0.9 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.3 | 0.6 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.3 | 3.7 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.3 | 0.6 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.3 | 0.6 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.3 | 4.5 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.3 | 0.6 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.3 | 0.6 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.3 | 6.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.3 | 0.9 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.3 | 1.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.3 | 0.9 | GO:0033483 | oxygen homeostasis(GO:0032364) gas homeostasis(GO:0033483) |
0.3 | 1.4 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.3 | 0.9 | GO:0060174 | limb bud formation(GO:0060174) |
0.3 | 2.9 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.3 | 2.6 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.3 | 1.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.3 | 0.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.3 | 2.5 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.3 | 9.0 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.3 | 0.8 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.3 | 0.8 | GO:0014028 | notochord formation(GO:0014028) |
0.3 | 0.8 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.3 | 0.8 | GO:0035933 | glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
0.3 | 2.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 2.8 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.3 | 1.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 3.0 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.3 | 0.5 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.3 | 1.3 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.3 | 5.1 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.3 | 0.8 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.3 | 2.4 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
0.3 | 1.3 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.3 | 2.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.3 | 0.5 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.3 | 1.0 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.3 | 0.3 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.3 | 0.5 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.3 | 1.0 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.3 | 1.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 0.2 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.2 | 1.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 5.5 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.2 | 1.7 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.2 | 0.5 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 0.5 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 3.6 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 1.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 2.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 0.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.2 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 2.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.7 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 2.4 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.2 | 0.9 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 0.9 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.2 | 0.2 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.2 | 0.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.9 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.2 | 0.2 | GO:0061183 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
0.2 | 0.5 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.2 | 0.5 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 6.7 | GO:0019228 | neuronal action potential(GO:0019228) |
0.2 | 0.5 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.2 | 0.9 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.2 | 0.2 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.2 | 0.4 | GO:0072319 | clathrin coat disassembly(GO:0072318) vesicle uncoating(GO:0072319) |
0.2 | 0.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.2 | GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) |
0.2 | 1.7 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.2 | 0.2 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.2 | 2.3 | GO:0031000 | response to caffeine(GO:0031000) |
0.2 | 0.2 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.2 | 0.4 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.2 | 0.2 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.2 | 0.2 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.2 | 0.2 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.2 | 8.9 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.2 | 0.6 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.2 | 0.4 | GO:2001023 | regulation of response to drug(GO:2001023) positive regulation of response to drug(GO:2001025) |
0.2 | 2.1 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 0.6 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 0.8 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 2.2 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 0.4 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 0.8 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 1.0 | GO:0035989 | tendon development(GO:0035989) |
0.2 | 0.4 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 0.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 0.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.6 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 1.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 1.1 | GO:0043586 | tongue development(GO:0043586) |
0.2 | 0.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 0.4 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 1.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.4 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.2 | 0.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 0.2 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.2 | 1.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.2 | 0.7 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 0.5 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.2 | 0.5 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 0.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 0.4 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.2 | 0.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.9 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.2 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.5 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.2 | 0.5 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.5 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.2 | 4.5 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.2 | 1.5 | GO:0032401 | establishment of melanosome localization(GO:0032401) |
0.2 | 0.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 1.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.3 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.2 | 0.5 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.2 | 1.6 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.2 | 0.2 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.2 | 0.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.2 | 0.5 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.2 | 0.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 0.3 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.2 | 0.3 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 0.8 | GO:0060004 | reflex(GO:0060004) |
0.2 | 1.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 1.2 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.1 | 0.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 3.3 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.6 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.1 | GO:0048382 | mesendoderm development(GO:0048382) |
0.1 | 1.6 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.1 | 0.3 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.4 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 1.9 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 1.0 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 1.9 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.1 | 0.1 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.1 | 0.6 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.4 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.7 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 0.4 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.6 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.7 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.3 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.7 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 1.0 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.3 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.1 | 1.7 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.6 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.1 | 0.3 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.1 | 0.3 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.1 | 0.4 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 2.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.5 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.5 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.1 | 0.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.8 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.1 | 0.3 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 6.5 | GO:0032760 | positive regulation of tumor necrosis factor production(GO:0032760) |
0.1 | 0.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 1.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.5 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.1 | 0.6 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.1 | 0.4 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 0.1 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 1.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 1.0 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.1 | 0.2 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.1 | 0.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.9 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.2 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.1 | 0.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.2 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.1 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.2 | GO:0090135 | actin filament branching(GO:0090135) |
0.1 | 0.6 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.1 | 0.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 2.6 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.1 | 0.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.1 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.1 | 0.2 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.1 | 0.9 | GO:0030828 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.4 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.1 | 0.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.3 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 0.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.1 | GO:0002884 | type IV hypersensitivity(GO:0001806) negative regulation of hypersensitivity(GO:0002884) |
0.1 | 0.2 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.1 | 0.2 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.2 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.5 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 0.1 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.1 | 0.2 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) regulation of Cdc42 protein signal transduction(GO:0032489) |
0.1 | 0.1 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.1 | 0.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.3 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.4 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.1 | 5.1 | GO:0050808 | synapse organization(GO:0050808) |
0.1 | 0.9 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.3 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.1 | 0.3 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.6 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.1 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.1 | 0.2 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.1 | 0.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.1 | 0.1 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 0.6 | GO:1900113 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.3 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 0.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.6 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 2.2 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.4 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.2 | GO:0010513 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.1 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.1 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.1 | 0.3 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 0.4 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.9 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.1 | 0.2 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.2 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.1 | 0.4 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.6 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.3 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.1 | 1.9 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.6 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 1.1 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 0.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.1 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.1 | 0.1 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.1 | 0.4 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.7 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.2 | GO:0048846 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.1 | 0.5 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.2 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 1.5 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.2 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.1 | 0.3 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) |
0.1 | 1.3 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 1.0 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.1 | 0.2 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.1 | 0.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.4 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.2 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.2 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 0.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.4 | GO:0002488 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
0.1 | 0.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.1 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) |
0.1 | 0.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.1 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.3 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.1 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.1 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.1 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.3 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.1 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.1 | 0.5 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.5 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.1 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.4 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.3 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.4 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.1 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.1 | 0.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.4 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 1.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.1 | 0.5 | GO:0006582 | melanin metabolic process(GO:0006582) |
0.1 | 0.9 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.4 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.1 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 0.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.1 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.1 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.1 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.1 | 0.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.1 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 0.3 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 0.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.1 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.1 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.5 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.1 | 0.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.1 | 1.7 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.2 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.1 | 0.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.6 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.4 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.4 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.1 | 0.2 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.1 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.1 | 0.7 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.1 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.1 | 0.1 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.1 | 0.3 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 0.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.0 | 3.2 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.0 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.0 | GO:0043416 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.5 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.0 | 0.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.0 | 0.7 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.0 | 0.1 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.0 | 0.2 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.0 | 0.3 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.0 | GO:2000109 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.0 | 0.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.0 | 0.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.0 | 0.6 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.0 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.0 | 0.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 1.5 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.2 | GO:0032095 | regulation of response to food(GO:0032095) |
0.0 | 0.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.1 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.3 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.0 | 0.3 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.1 | GO:0070305 | response to cGMP(GO:0070305) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.0 | 0.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.2 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.0 | 0.0 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.1 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.0 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.0 | GO:0090335 | negative regulation of oligodendrocyte differentiation(GO:0048715) regulation of brown fat cell differentiation(GO:0090335) |
0.0 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.1 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.0 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.0 | 0.0 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
0.0 | 0.8 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.5 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.0 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.0 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.0 | 0.2 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.1 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.9 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.0 | 0.1 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.0 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.0 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.0 | 0.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.5 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.0 | 0.1 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.1 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 0.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.2 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.0 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.0 | 0.2 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.0 | 0.0 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.3 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.2 | GO:0051324 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.2 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.3 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.0 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.0 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.2 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.2 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.4 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.0 | 0.1 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.0 | 0.0 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.1 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.0 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.0 | 0.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.0 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.0 | 0.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.1 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.0 | 0.0 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.0 | 0.2 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
0.0 | 1.4 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
0.0 | 0.0 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.0 | 0.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.1 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.0 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.1 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.0 | 0.1 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.0 | 0.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.0 | 0.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.1 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.0 | 1.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.0 | 0.0 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.1 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.1 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.0 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.0 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.0 | 0.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.2 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
0.0 | 0.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.0 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.0 | 0.6 | GO:0045598 | regulation of fat cell differentiation(GO:0045598) |
0.0 | 0.0 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.0 | 0.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.2 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.0 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.0 | 0.1 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.0 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.0 | 0.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.0 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.0 | 0.0 | GO:0071450 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.0 | 0.3 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.0 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.0 | 0.1 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.0 | 0.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 0.0 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.0 | 0.0 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.0 | 0.1 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.0 | GO:0090071 | regulation of ribosome biogenesis(GO:0090069) negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.0 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.0 | 0.0 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.0 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.0 | 0.0 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.0 | 0.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.0 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.0 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.0 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.0 | 0.5 | GO:1904591 | positive regulation of protein import(GO:1904591) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.0 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.0 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.0 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.0 | 0.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.0 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.0 | 0.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.0 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.0 | 0.0 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.0 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.0 | 0.0 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.0 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.1 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.0 | 0.1 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.0 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.0 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.0 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.0 | 0.0 | GO:1903624 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.0 | 0.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.0 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.0 | 0.0 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.0 | 0.0 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.0 | 0.0 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.0 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.0 | 0.0 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 2.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.8 | 5.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.5 | 4.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.2 | 5.9 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.1 | 8.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.1 | 4.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.0 | 5.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.9 | 9.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.8 | 3.1 | GO:0033010 | paranodal junction(GO:0033010) |
0.8 | 3.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.7 | 4.2 | GO:0032584 | growth cone membrane(GO:0032584) |
0.7 | 19.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.7 | 6.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.7 | 2.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.6 | 7.1 | GO:0097449 | astrocyte projection(GO:0097449) |
0.6 | 3.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.6 | 5.5 | GO:0005883 | neurofilament(GO:0005883) |
0.6 | 6.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.6 | 3.3 | GO:0043194 | axon initial segment(GO:0043194) |
0.5 | 26.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.5 | 1.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.5 | 3.6 | GO:0043083 | synaptic cleft(GO:0043083) |
0.5 | 12.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.5 | 1.5 | GO:0072534 | perineuronal net(GO:0072534) |
0.5 | 2.0 | GO:1990696 | USH2 complex(GO:1990696) |
0.5 | 14.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.5 | 4.7 | GO:0030673 | axolemma(GO:0030673) |
0.5 | 2.3 | GO:0097433 | dense body(GO:0097433) |
0.4 | 1.8 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.4 | 5.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.4 | 1.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.4 | 45.8 | GO:0030427 | site of polarized growth(GO:0030427) |
0.4 | 5.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 7.2 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.4 | 2.9 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.4 | 1.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.4 | 5.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.4 | 1.5 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 2.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.4 | 1.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 51.1 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 1.0 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 0.9 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.3 | 25.2 | GO:0043204 | perikaryon(GO:0043204) |
0.3 | 0.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 1.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 1.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 0.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 2.5 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 2.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 2.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 3.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 3.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 3.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 0.7 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 10.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 2.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 5.2 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 2.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 0.9 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 1.0 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 0.6 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 0.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 2.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.6 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 1.2 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 1.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 1.4 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 1.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.8 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.8 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.1 | 2.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.8 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 0.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.5 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.5 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 3.8 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 1.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 6.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 7.7 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 5.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 4.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.2 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 0.5 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.3 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 1.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.3 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.1 | 0.2 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.2 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.3 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.9 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.2 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.3 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.0 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 0.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.1 | GO:0005818 | aster(GO:0005818) |
0.0 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.7 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 9.5 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.9 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 8.8 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.0 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.0 | GO:0044393 | microspike(GO:0044393) |
0.0 | 0.2 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.8 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.3 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.0 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.1 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.1 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.2 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.0 | GO:0031523 | Myb complex(GO:0031523) |
0.0 | 1.0 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.0 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 1.2 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.0 | 0.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.2 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 4.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.0 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 0.0 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.0 | 0.0 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.0 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 18.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.1 | 15.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.5 | 7.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.2 | 6.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
2.1 | 6.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.8 | 7.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.8 | 12.8 | GO:0003680 | AT DNA binding(GO:0003680) |
1.8 | 7.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.8 | 15.8 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.7 | 5.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.7 | 11.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.6 | 9.8 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.5 | 4.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.5 | 2.9 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.3 | 6.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.3 | 6.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.2 | 3.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.1 | 6.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.1 | 7.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.1 | 3.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.1 | 3.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.0 | 3.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.0 | 5.9 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.0 | 1.9 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.0 | 3.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.9 | 2.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.9 | 7.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.8 | 2.5 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.8 | 6.5 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.8 | 2.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.8 | 20.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.8 | 2.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.7 | 3.6 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.7 | 1.4 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.7 | 15.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.7 | 3.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.7 | 0.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.7 | 2.0 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.6 | 1.9 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.6 | 4.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.6 | 1.9 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.6 | 6.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.6 | 4.3 | GO:0043495 | protein anchor(GO:0043495) |
0.5 | 4.4 | GO:0036122 | BMP binding(GO:0036122) |
0.5 | 1.5 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.5 | 7.5 | GO:0031402 | sodium ion binding(GO:0031402) |
0.5 | 3.0 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.5 | 1.9 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.5 | 4.2 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.5 | 2.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.5 | 4.7 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.5 | 1.9 | GO:0030955 | potassium ion binding(GO:0030955) |
0.4 | 1.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.4 | 2.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.4 | 1.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.4 | 1.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.4 | 4.8 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.4 | 1.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.4 | 5.5 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.4 | 1.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.4 | 9.9 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.4 | 7.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.4 | 9.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.4 | 3.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.4 | 1.5 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 0.4 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.3 | 4.5 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 1.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 0.7 | GO:0051373 | FATZ binding(GO:0051373) |
0.3 | 1.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 1.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 1.0 | GO:0048030 | disaccharide binding(GO:0048030) |
0.3 | 1.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.3 | 3.2 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.3 | 7.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 1.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 4.7 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.3 | 0.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 3.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.3 | 5.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 1.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.3 | 3.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.3 | 0.3 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.3 | 2.3 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 1.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.3 | 0.9 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 0.9 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.3 | 1.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 0.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 0.3 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.3 | 1.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.3 | 4.7 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.3 | 0.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 0.5 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.3 | 1.9 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.3 | 1.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 0.8 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 2.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 6.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 5.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 4.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 0.7 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 2.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 1.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 1.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 3.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.7 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.2 | 0.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 0.9 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 1.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 2.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 3.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 0.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 0.6 | GO:0005119 | smoothened binding(GO:0005119) |
0.2 | 0.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 5.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 0.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 1.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 4.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 1.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 5.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.2 | 3.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 0.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 1.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.2 | 0.9 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.2 | 0.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 0.6 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 1.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 0.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 0.4 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.2 | 1.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 2.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 5.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 0.5 | GO:0001226 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.2 | 1.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 2.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 0.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 2.4 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 3.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 2.3 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 0.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 0.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 3.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 3.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 5.5 | GO:0080131 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.2 | 3.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 0.6 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.2 | 0.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 0.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 0.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 0.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 1.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 0.7 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 2.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.4 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.4 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 2.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.8 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 1.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 3.0 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.6 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.6 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 1.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.5 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 2.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 1.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 1.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 2.7 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 1.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 1.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.4 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 1.0 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 0.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.7 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 1.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 1.5 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 1.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 1.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.5 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.8 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.9 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.4 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 1.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 0.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.2 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.1 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.1 | 0.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.9 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.4 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.3 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 0.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.4 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 1.7 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 3.2 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 5.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.0 | 0.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.4 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.2 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.0 | 0.4 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 3.1 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.1 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 4.6 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.5 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0015265 | urea channel activity(GO:0015265) |
0.0 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 12.5 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.0 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.8 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.7 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.0 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.1 | GO:0034845 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.0 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.1 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.0 | 0.4 | GO:0018602 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) DNA-N1-methyladenine dioxygenase activity(GO:0043734) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.0 | 0.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.5 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.0 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.0 | GO:0070697 | activin receptor binding(GO:0070697) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.0 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.0 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.0 | 0.0 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 1.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 0.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.0 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.0 | 0.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.1 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.0 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.0 | 0.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 8.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 11.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 11.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.4 | 9.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 4.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 10.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 0.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.3 | 3.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 19.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.3 | 9.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 3.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 4.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 0.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 2.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 0.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 3.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 3.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 4.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 1.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 1.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 4.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 1.6 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 2.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.7 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 17.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 2.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.8 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.8 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.0 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 1.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 19.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.0 | 8.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.9 | 13.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.9 | 23.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.7 | 9.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.7 | 13.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.7 | 0.7 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.5 | 5.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.5 | 1.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.5 | 0.5 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.5 | 1.4 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.4 | 3.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.4 | 6.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.4 | 4.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 4.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 3.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 2.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 4.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 1.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 1.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 3.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 7.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 0.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 4.5 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 5.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 5.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 2.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 9.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 3.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 3.1 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.2 | 1.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 2.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 0.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.2 | 2.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 1.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 1.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 6.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 2.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 3.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 2.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 2.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 4.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 0.2 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 1.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 2.3 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.1 | 1.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 1.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 6.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.3 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.1 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.1 | 4.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 0.7 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.1 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 6.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 1.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.1 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.0 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |